U.S. flag

An official website of the United States government

NM_000127.3(EXT1):c.803G>A (p.Gly268Glu) AND Multiple congenital exostosis

Germline classification:
Pathogenic (1 submission)
Last evaluated:
May 29, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001859476.6

Allele description [Variation Report for NM_000127.3(EXT1):c.803G>A (p.Gly268Glu)]

NM_000127.3(EXT1):c.803G>A (p.Gly268Glu)

Gene:
EXT1:exostosin glycosyltransferase 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
8q24.11
Genomic location:
Preferred name:
NM_000127.3(EXT1):c.803G>A (p.Gly268Glu)
HGVS:
  • NC_000008.11:g.118110244C>T
  • NG_007455.2:g.6576G>A
  • NM_000127.3:c.803G>AMANE SELECT
  • NP_000118.2:p.Gly268Glu
  • NP_000118.2:p.Gly268Glu
  • LRG_493t1:c.803G>A
  • LRG_493:g.6576G>A
  • LRG_493p1:p.Gly268Glu
  • NC_000008.10:g.119122483C>T
  • NM_000127.2:c.803G>A
Protein change:
G268E
Links:
dbSNP: rs886039352
NCBI 1000 Genomes Browser:
rs886039352
Molecular consequence:
  • NM_000127.3:c.803G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Multiple congenital exostosis (EXT)
Synonyms:
MULTIPLE CARTILAGINOUS EXOSTOSES; Hereditary multiple osteochondromas; Multiple exostoses; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0005508; MedGen: C0015306; Orphanet: 321; OMIM: PS133700; Human Phenotype Ontology: HP:0002762

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002236637Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(May 29, 2021)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Analysis of mutations in EXT1 and EXT2 in Brazilian patients with multiple osteochondromas.

Santos SCL, Rizzo IMPO, Takata RI, Speck-Martins CE, Brum JM, Sollaci C.

Mol Genet Genomic Med. 2018 May;6(3):382-392. doi: 10.1002/mgg3.382. Epub 2018 Mar 12.

PubMed [citation]
PMID:
29529714
PMCID:
PMC6014457

Multiple osteochondromas: mutation update and description of the multiple osteochondromas mutation database (MOdb).

Jennes I, Pedrini E, Zuntini M, Mordenti M, Balkassmi S, Asteggiano CG, Casey B, Bakker B, Sangiorgi L, Wuyts W.

Hum Mutat. 2009 Dec;30(12):1620-7. doi: 10.1002/humu.21123. Review.

PubMed [citation]
PMID:
19810120
See all PubMed Citations (3)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002236637.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This variant has been observed in individual(s) with multiple osteochondromatosis (PMID: 29529714). ClinVar contains an entry for this variant (Variation ID: 265126). This variant is not present in population databases (ExAC no frequency). This sequence change replaces glycine with glutamic acid at codon 268 of the EXT1 protein (p.Gly268Glu). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and glutamic acid. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt EXT1 protein function. For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.p.Gly268 amino acid residue in EXT1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 19810120, Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024